Expanded Access Program for Epcoritamab

Clinical trial NCT05733650 · APPROVED_FOR_MARKETING

Trial details

NCT number: NCT05733650
Sponsor: Genmab
Status: APPROVED_FOR_MARKETING
Study type: EXPANDED_ACCESS

Large B-cell Lymphoma Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Primary Mediastinal Large B-cell Lymphoma (PMBCL)High Grade B-cell Lymphoma (HGBCL)Grade 3B Follicular Lymphoma

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.